Vital staining with indocyanine green: A review of the clinical and experimental studies relating to safety

Eye

Volumn 23, Issue 3, 2009, Pages 504-518

  Stanescu Segall, D ^a   Jackson, T L ^a,b  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Indocyanine green; Infracyanine green; Macular hole; Review; Safety; Toxicity

Indexed keywords

DYE; INDOCYANINE GREEN; INFRACYANINE GREEN; TRYPAN BLUE; UNCLASSIFIED DRUG; COLORING AGENT;

CATARACT; CATARACT EXTRACTION; CENTRAL SCOTOMA; CLINICAL TRIAL; DIABETIC MACULAR EDEMA; ELECTRON MICROSCOPY; ELECTROPHYSIOLOGY; EPIRETINAL MEMBRANE; EYE SURGERY; HISTOPATHOLOGY; HUMAN; NONHUMAN; OPTIC NERVE; OPTICAL COHERENCE TOMOGRAPHY; RECURRENT DISEASE; RETINA ANGIOGRAPHY; RETINA DETACHMENT; RETINA MACULA HOLE; RETINA MACULA LUTEA; REVIEW; RISK ASSESSMENT; STAINING; SURGICAL TECHNIQUE; TRANSMISSION ELECTRON MICROSCOPY; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD DEFECT; VITAL STAIN; VITRECTOMY; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DIAGNOSTIC USE; DISEASE MODEL; DRUG EFFECTS; EVIDENCE BASED MEDICINE; PEROPERATIVE CARE; PROCEDURES; VISUAL DISORDER; VISUAL FIELD;

ANIMALS; COLORING AGENTS; DISEASE MODELS, ANIMAL; EPIRETINAL MEMBRANE; EVIDENCE-BASED MEDICINE; HUMANS; INDOCYANINE GREEN; INTRAOPERATIVE CARE; STAINING AND LABELING; VISION DISORDERS; VISUAL FIELDS;

EID: 62549108607     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.249     Document Type: Review

References (111)

1. Beutel J, Dahmen G, Ziegler A, Hoerauf H. Internal limiting membrane peeling with indocyanine green or trypan blue in macular hole surgery: a randomized trial. Arch Ophthalmol 2007; 125: 326-332.
2. Kwok AK, Lai TY, Yuen KS, Tam BS, Wong VW. Macular hole surgery with or without indocyanine green-stained internal limiting membrane peeling. Clin Experiment Ophthalmol 2003; 31: 470-475.
3. Kwok AK, Lai TY, Yew DT, Li WW. Internal limiting membrane staining with various concentrations of indocyanine green dye under air in macular surgeries. Am J Ophthalmol 2003; 136: 223-230.
4. Da Mata AP, Burk SE, Riemann CD, Rosa RHJ, Snyder ME, Petersen MR et al. Indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for macular hole repair. Ophthalmology 2001; 108: 1187-1192.
5. Da Mata AP, Burk SE, Foster RE, Riemann CD, Petersen MR, Nehemy MB et al. Long-term follow-up of indocyanine green-assisted peeling of the retinal internal limiting membrane during vitrectomy surgery for idiopathic macular hole repair. Ophthalmology 2004; 111: 2246-2253.
6. Kumar A, Prakash G, Singh RP. Indocyanine green enhanced maculorhexis in macular hole surgery. Indian J Ophthalmol 2002; 50: 123-126.
7. Apostolopoulos MN, Koutsandrea CN, Moschos MN, Alonistiotis DA, Papaspyrou AE, Mallias JA et al. Evaluation of successful macular hole surgery by optical coherence tomography and multifocal electroretinography. Am J Ophthalmol 2002; 134: 667-674.
8. Lochhead J, Jones E, Chui D, Lake S, Karia N, Patel CK et al. Outcome of ICG-assisted ILM peel in macular hole surgery. Eye 2004; 18: 804-808.
9. Sheidow TG, Blinder KJ, Holekamp N, Joseph D, Shah G, Grand MG et al. Outcome results in macular hole surgery: an evaluation of internal limiting membrane peeling with and without indocyanine green. Ophthalmology 2003; 110: 1697-1701.
10. Wolf S, Reichel MB, Wiedemann P, Schnurrbusch UE. Clinical findings in macular hole surgery with indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2003; 241: 589-592.
11. Das T, Parida S, Majji AB. Does internal limiting membrane peeling in macular hole surgery improve reading vision? Indian J Ophthalmol 2003; 51: 251-254.
12. Lai MM, Williams GA. Anatomical and visual outcomes of idiopathic macular hole surgery with internal limiting membrane removal using low-concentration indocyanine green. Retina 2007; 27: 477-482.
13. Kadonosono K, Itoh N, Uchio E, Nakamura S, Ohno S. Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol 2000; 118: 1116-1118.
14. Ando F, Sasano K, Suzuki F, Ohba N. Indocyanine green-assisted ILM peeling in macular hole surgery revisited. Am J Ophthalmol 2004; 138: 886-887.
15. Kwok AK, Li WW, Pang CP, Lai TY, Yam GH, Chan NR et al. Indocyanine green staining and removal of internal limiting membrane in macular hole surgery: histology and outcome. Am J Ophthalmol 2001; 132: 178-183.
16. Kanda S, Uemura A, Yamashita T, Kita H, Yamakiri K, Sakamoto T. Visual field defects after intravitreous administration of indocyanine green in macular hole surgery. Arch Ophthalmol 2004; 122: 1447-1451.
17. Nagai N, Ishida S, Shinoda K, Imamura Y, Noda K, Inoue M. Surgical effects and complications of indocyanine green-assisted internal limiting membrane peeling for idiopathic macular hole. Acta Ophthalmol Scand 2007; 85: 883-889.
18. Tsuiki E, Fujikawa A, Miyamura N, Yamada K, Mishima K, Kitaoka T. Visual field defects after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2007; 143: 704-705.
19. Gass CA, Haritoglou C, Schaumberger M, Kampik A. Functional outcome of macular hole surgery with and without indocyanine green-assisted peeling of the internal limiting membrane. Graefes Arch Clin Exp Ophthalmol 2003; 241: 716-720.
20. Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane in macular hole surgery affects visual outcome: a clinicopathologic correlation. Am J Ophthalmol 2002; 134: 836-841.
21. Tognetto D, Grandin R, Sanguinetti G, Minutola D, Di Nicola M, Di Mascio R et al. Internal limiting membrane removal during macular hole surgery: results of a multicenter retrospective study. Ophthalmology 2006; 113: 1401-1410.
22. Engelbrecht NE, Freeman J, Sternberg PJ, Aaberg TMS, Aaberg TMJ, Martin DF et al. Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol 2002; 133: 89-94.
23. Poliner LS, Tornambe PE. Retinal pigment epitheliopathy after macular hole surgery. Ophthalmology 1992; 99: 1671-1677.
24. Mavrofrides E, Smiddy WE, Kitchens JW, Salicone A, Feuer W. Indocyanine green-assisted internal limiting membrane peeling for macular holes: toxicity? Retina 2006; 26: 637-644.
25. Miura M, Elsner AE, Osako M, Iwasaki T, Okano T, Usui M. Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular hole. Retina 2003; 23: 561-563.
26. Yamashita T, Uemura A, Kita H, Sakamoto T. Analysis of the retinal nerve fiber layer after indocyanine green-assisted vitrectomy for idiopathic macular holes. Ophthalmology 2006; 113: 280-284.
27. Haritoglou C, Neubauer AS, Gandorfer A, Thiel M, Kampik A. Indocyanine green for successful repair of a long-standing macular hole. Am J Ophthalmol 2003; 136: 389-391.
28. Welch JC. Dehydration injury as a possible cause of visual field defect after pars plana vitrectomy for macular hole. Am J Ophthalmol 1997; 124: 698-699.
29. Hirata A, Yonemura N, Hasumura T, Murata Y, Negi A. Effect of infusion air pressure on visual field defects after macular hole surgery. Am J Ophthalmol 2000; 130: 611-616.
30. Kerrison JB, Haller JA, Elman M, Miller NR. Visual field loss following vitreous surgery. Arch Ophthalmol 1996; 114: 564-569.
31. Melberg NS, Thomas MA. Visual field loss after pars plana vitrectomy with air/fluid exchange. Am J Ophthalmol 1995; 120: 386-388.
32. Yan H, Dhurjon L, Chow DR, Williams D, Chen JC. Visual field defect after pars plana vitrectomy. Ophthalmology 1998; 105: 1612-1616.
33. Ito Y, Terasaki H, Takahashi A, Yamakoshi T, Kondo M, Nakamura M. Dissociated optic nerve fiber layer appearance after internal limiting membrane peeling for idiopathic macular holes. Ophthalmology 2005; 112: 1415-1420.
34. Boldt HC, Munden PM, Folk JC, Mehaffey MG. Visual field defects after macular hole surgery. Am J Ophthalmol 1996; 122: 371-381.
35. Paques M, Massin P, Santiago PY, Spielmann AC, Gaudric A. Visual field loss after vitrectomy for full-thickness macular holes. Am J Ophthalmol 1997; 124: 88-94.
36. Arima T, Uemura A, Otsuka S, Doi N, Nakao K. Macular hole surgery-associated peripheral visual field loss. Jpn J Ophthalmol 1998; 42: 476-483.
37. Ohji M, Nao-I N, Saito Y, Hayashi A, Tano Y. Prevention of visual field defect after macular hole surgery by passing air used for fluid-air exchange through water. Am J Ophthalmol 1999; 127: 62-66.
38. Hutton WL, Fuller DG, Snyder WB, Fellman RL, Swanson WH. Visual field defects after macular hole surgery. A new finding. Ophthalmology 1996; 103: 2152-2158; discussion 2158-9.
39. Nakamura H, Hayakawa K, Imaizumi A, Sakai M, Sawaguchi S. Persistence of retinal indocyanine green dye following vitreous surgery. Ophthalmic Surg Lasers Imaging 2005; 36: 37-45.
40. Hillenkamp J, Saikia P, Gora F, Sachs HG, Lohmann CP, Roider J et al. Macular function and morphology after peeling of idiopathic epiretinal membrane with and without the assistance of indocyanine green. Br J Ophthalmol 2005; 89: 437-443.
41. Jackson TL, Antcliff RJ, Hillenkamp J, Marshall J. Human retinal molecular weight exclusion limit and estimate of species variation. Invest Ophthalmol Vis Sci 2003; 44: 2141-2146.
42. Ando F, Yasui O, Hirose H, Ohba N. Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling. Graefes Arch Clin Exp Ophthalmol 2004; 242: 995-999.
43. Haritoglou C, Gandorfer A, Gass CA, Schaumberger M, Ulbig MW, Kampik A. The effect of indocyanine-green on functional outcome of macular pucker surgery. Am J Ophthalmol 2003; 135: 328-337.
44. Bardak Y, Cekic O, Tig SU. Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema. Eye 2006; 20: 1357-1359.
45. Kamura Y, Sato Y, Isomae T, Shimada H. Effects of internal limiting membrane peeling in vitrectomy on diabetic cystoid macular edema patients. Jpn J Ophthalmol 2005; 49: 297-300.
46. Ferencz M, Somfai GM, Farkas A, Kovacs I, Lesch B, Recsan Z et al. Functional assessment of the possible toxicity of indocyanine green dye in macular hole surgery. Am J Ophthalmol 2006; 142: 765-770.
47. Horio N, Horiguchi M. Effect on visual outcome after macular hole surgery when staining the internal limiting membrane with indocyanine green dye. Arch Ophthalmol 2004; 122: 992-996.
48. Kersey TL, Bolton A, Patel CK. Serial autofluorescence imaging over two years following indocyanine green-assisted internal limiting membrane peel for macular hole. Clin Experiment Ophthalmol 2005; 33: 538-539.
49. Hirata A, Inomata Y, Kawaji T, Tanihara H. Persistent subretinal indocyanine green induces retinal pigment epithelium atrophy. Am J Ophthalmol 2003; 136: 353-355.
50. Ciardella AP, Schiff W, Barile G, Vidne O, Sparrow J, Langton K et al. Persistent indocyanine green fluorescence after vitrectomy for macular hole. Am J Ophthalmol 2003; 136: 174-177.
51. Sekiryu T, Iida T. Long-term observation of fundus infrared fluorescence after indocyanine green-assisted vitrectomy. Retina 2007; 27: 190-197.
52. Sayanagi K, Ikuno Y, Soga K, Sawa M, Oshima Y, Kamei M et al. Residual indocyanine green fluorescence pattern after vitrectomy for idiopathic macular hole with internal limiting membrane peeling. Br J Ophthalmol 2007; 91: 939-944.
53. Sayanagi K, Ikuno Y, Soga K, Sawa M, Tano Y. Residual indocyanine green fluorescence pattern after vitrectomy with internal limiting membrane peeling in high myopia. Am J Ophthalmol 2007; 144: 600-607.
54. Ashikari M, Ozeki H, Tomida K, Sakurai E, Tamai K, Ogura Y. Long-term retention of dye after indocyanine green-assisted internal limiting membrane peeling. Jpn J Ophthalmol 2006; 50: 349-353.
55. Facino M, Mochi B, Lai S, Terrile R. A simple way to prevent indocyanine green from entering the subretinal space during vitrectomy for retinal detachment due to myopic macular hole. Eur J Ophthalmol 2004; 14: 269-271.
56. Olson JL, On AV, Mandava N. Protecting the retinal pigment epithelium during macular hole surgery. Clin Experiment Ophthalmol 2005; 33: 576-577.
57. Rizzo S, Belting C, Genovesi-Ebert F, Vento A, Cresti F. Modified technique for safer indocyanine-green-assisted peeling of the internal limiting membrane during vitrectomy for macular hole repair. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1615-1619.
58. Lai CC, Wu WC, Chuang LH, Yeung L, Chen TL, Lin KK. Prevention of indocyanine green toxicity on retinal pigment epithelium with whole blood in stain-assisted macular hole surgery. Ophthalmology 2005; 112: 1409-1414.
59. Saito M, Iida T. A surgical technique to protect the macular hole in indocyanine green-assisted vitrectomy. Ophthalmic Surg Lasers Imaging 2006; 37: 511-515.
60. Nakamura H, Hayakawa K, Sawaguchi S, Gaja T. Removal of retinal indocyanine green dye by autologous serum irrigation in macular hole surgery. Retina 2005; 25: 736-741.
61. Hillenkamp J, Saikia P, Herrmann WA, Framme C, Gabel VP, Sachs HG. Surgical removal of idiopathic epiretinal membrane with or without the assistance of indocyanine green: a randomised controlled clinical trial. Graefes Arch Clin Exp Ophthalmol 2007; 245: 973-979.
62. Lee JE, Yoon TJ, Oum BS, Lee JS, Choi HY. Toxicity of indocyanine green injected into the subretinal space: subretinal toxicity of indocyanine green. Retina 2003; 23: 675-681.
63. Kawaji T, Hirata A, Inomata Y, Koga T, Tanihara H. Morphological damage in rabbit retina caused by subretinal injection of indocyanine green. Graefes Arch Clin Exp Ophthalmol 2004; 242: 158-164.
64. Maia M, Kellner L, de Juan EJ, Smith R, Farah ME, Margalit E et al. Effects of indocyanine green injection on the retinal surface and into the subretinal space in rabbits. Retina 2004; 24: 80-91.
65. Penha FM, Maia M, Eid Farah M, Principe AH, Freymuller EH, Maia A et al. Effects of subretinal injections of indocyanine green, trypan blue, and glucose in rabbit eyes. Ophthalmology 2007; 114: 899-908.
66. Yip HK, Lai TY, So KF, Kwok AK. Retinal ganglion cells toxicity caused by photosensitising effects of intravitreal indocyanine green with illumination in rat eyes. Br J Ophthalmol 2006; 90: 99-102.
67. Kwok AK, Lai TY, Yeung CK, Yeung YS, Li WW, Chiang SW. The effects of indocyanine green and endoillumination on rabbit retina: an electroretinographic and histological study. Br J Ophthalmol 2005; 89: 897-900.
68. Maia M, Margalit E, Lakhanpal R, Tso MO, Grebe R, Torres G et al. Effects of intravitreal indocyanine green injection in rabbits. Retina 2004; 24: 69-79.
69. Sato Y, Tomita H, Sugano E, Isago H, Yoshida M, Tamai M. Evaluation of indocyanine green toxicity to rat retinas. Ophthalmologica 2006; 220: 153-158.
70. Goldstein M, Zemel E, Loewenstein A, Perlman I. Retinal toxicity of indocyanine green in albino rabbits. Invest Ophthalmol Vis Sci 2006; 47: 2100-2107.
71. Chao AN, Chen SN, Kuo YH. Retinal function and histologic changes following intravitreal injection of indocyanine green in a rabbit model. J Ocul Pharmacol Ther 2004; 20: 450-459.
72. Enaida H, Sakamoto T, Hisatomi T, Goto Y, Ishibashi T. Morphological and functional damage of the retina caused by intravitreous indocyanine green in rat eyes. Graefes Arch Clin Exp Ophthalmol 2002; 240: 209-213.
73. Cekiç O, Morimoto T, Ohji M, Sawa M, Hasegawa T, Sakaguchi H et al. Nonaxoplasmic transfer of indocyanine green into the optic nerve after intravitreal application. Retina 2004; 24: 412-415.
74. Paques M. Nonaxoplasmic transfer of indocyanine green into the optic nerve after intravitreal application. Retina 2005; 25: 544; author reply 544-544; author reply 545.
75. Czajka MP, McCuen BW 2nd, Cummings TJ, Nguyen H, Stinnett S, Wong F. Effects of indocyanine green on the retina and retinal pigment epithelium in a porcine model of retinal hole. Retina 2004; 24: 275-282.
76. Gandorfer A, Rohleder M, Charteris DG, Sethi C, Kampik A, Luthert P. Staining and peeling of the internal limiting membrane in the cat eye. Curr Eye Res 2005; 30: 977-987.
77. Saikia P, Maisch T, Kobuch K, Jackson TL, Baumler W, Szeimies RM et al. Safety testing of indocyanine green in an ex vivo porcine retina model. Invest Ophthalmol Vis Sci 2006; 47: 4998-5003.
78. Mennel S, Meyer CH, Tietjen A, Rodrigues EB, Schmidt JC. Patent blue: a novel vital dye in vitreoretinal surgery. Ophthalmologica 2006; 220: 190-193.
79. Sippy BD, Engelbrecht NE, Hubbard GB, Moriarty SE, Jiang S, Aaberg TMJ et al. Indocyanine green effect on cultured human retinal pigment epithelial cells: implication for macular hole surgery. Am J Ophthalmol 2001; 132: 433-435.
80. Murata M, Shimizu S, Horiuchi S, Sato S. The effect of indocyanine green on cultured retinal glial cells. Retina 2005; 25: 75-80.
81. Yam HF, Kwok AK, Chan KP, Lai TY, Chu KY, Lam DS et al. Effect of indocyanine green and illumination on gene expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 2003; 44: 370-377.
82. Stalmans P, Van Aken EH, Veckeneer M, Feron EJ, Stalmans I. Toxic effect of indocyanine green on retinal pigment epithelium related to osmotic effects of the solvent. Am J Ophthalmol 2002; 134: 282-285.
83. Rezai KA, Farrokh-Siar L, Ernest JT, van Seventer GA. Indocyanine green induces apoptosis in human retinal pigment epithelial cells. Am J Ophthalmol 2004; 137: 931-933.
84. Jackson TL, Hillenkamp J, Knight BC, Zhang JJ, Thomas D, Stanford MR et al. Safety testing of indocyanine green and trypan blue using retinal pigment epithelium and glial cell cultures. Invest Ophthalmol Vis Sci 2004; 45: 2778-2785.
85. Hsu SL, Kao YH, Wu WC. Effect of indocyanine green on the growth and viability of cultured human retinal pigment epithelial cells. J Ocul Pharmacol Ther 2004; 20: 353-362.
86. Kunikata H, Tomita H, Abe T, Murata H, Sagara Y, Sato H et al. Hypothermia protects cultured human retinal pigment epithelial cells against indocyanine green toxicity. J Ocul Pharmacol Ther 2007; 23: 35-39.
87. Jin Y, Uchida S, Yanagi Y, Aihara M, Araie M. Neurotoxic effects of trypan blue on rat retinal ganglion cells. Exp Eye Res 2005; 81: 395-400.
88. Iriyama A, Uchida S, Yanagi Y, Tamaki Y, Inoue Y, Matsuura K et al. Effects of indocyanine green on retinal ganglion cells. Invest Ophthalmol Vis Sci 2004; 45: 943-947.
89. Iriyama A, Yanagi Y, Uchida S, Tamaki Y, Aihara M, Obata R et al. Retinal nerve fibre layer damage after indocyanine green-assisted vitrectomy. Br J Ophthalmol 2004; 88: 1606-1607.
90. Ikagawa H, Yoneda M, Iwaki M, Isogai Z, Tsujii K, Yamazaki R et al. Chemical toxicity of indocyanine green damages retinal pigment epithelium. Invest Ophthalmol Vis Sci 2005; 46: 2531-2539.
91. Burk SE, Da Mata AP, Snyder ME, Rosa RHJ, Foster RE. Indocyanine green-assisted peeling of the retinal internal limiting membrane. Ophthalmology 2000; 107: 2010-2014.
92. Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Indocyanine green selectively stains the internal limiting membrane. Am J Ophthalmol 2001; 131: 387-388.
93. Gandorfer A, Haritoglou C, Gass CA, Ulbig MW, Kampik A. Indocyanine green-assisted peeling of the internal limiting membrane may cause retinal damage. Am J Ophthalmol 2001; 132: 431-433.
94. Gandorfer A, Haritoglou C, Gandorfer A, Kampik A. Retinal damage from indocyanine green in experimental macular surgery. Invest Ophthalmol Vis Sci 2003; 44: 316-323.
95. Grisanti S, Szurman P, Gelisken F, Aisenbrey S, Oficjalska-Mlynczak J, Bartz-Schmidt KU. Histological findings in experimental macular surgery with indocyanine green. Invest Ophthalmol Vis Sci 2004; 45: 282-286.
96. La Heij EC, Dieudonne SC, Mooy CM, Diederen RM, Liem AT, van Suylen RJ et al. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green. Am J Ophthalmol 2005; 140: 1123-1125.
97. Haritoglou C, Freyer W, Priglinger SG, Kampik A. Light absorbing properties of indocyanine green (ICG) in solution and after adsorption to the retinal surface: an ex-vivo approach. Graefes Arch Clin Exp Ophthalmol 2006; 244: 1196-1202.
98. Stalmans P, Feron EJ, Parys-Van Ginderdeuren R, Van Lommel A, Melles GR, Veckeneer M. Double vital staining using trypan blue and infracyanine green in macular pucker surgery. Br J Ophthalmol 2003; 87: 713-716.
99. Kolacny D, Parys-Vanginderdeuren R, Van Lommel A, Stalmans P. Vitrectomy with peeling of the inner limiting membrane for treating diabetic macular edema. Bull Soc Belge Ophtalmol 2005; 296: 15-23.
100. Lanzetta P, Polito A, Del Borrello M, Narayanan R, Shah VA, Frattolillo A et al. Idiopathic macular hole surgery with low-concentration infracyanine green-assisted peeling of the internal limiting membrane. Am J Ophthalmol 2006; 142: 771-776.
101. Van De Moere A, Stalmans P. Anatomical and visual outcome of macular hole surgery with infracyanine green-assisted peeling of the internal limiting membrane, endodrainage, and silicone oil tamponade. Am J Ophthalmol 2003; 136: 879-887.
102. Ullern M, Dubreuil F, Nourry H, Poisson F, Baudouin C. [Macular hole surgery with and without infracyanine-green-guided removal of the internal limiting membrane]. J Fr Ophtalmol 2007; 30: 53-57.
103. Ullern M, Roman S, Dhalluin JF, Lozato P, Grillon S, Bellefqih S et al. [Contribution of intravitreal infracyanine green to macular hole and epimacular membrane surgery: preliminary study]. J Fr Ophtalmol 2002; 25: 915-920.
104. Rivett K, Kruger L, Radloff S. Infracyanine-assisted internal limiting membrane peeling in macular hole repair: does it make a difference? Graefes Arch Clin Exp Ophthalmol 2004; 242: 393-396.
105. Husson-Danan A, Glacet-Bernard A, Soubrane G, Coscas G. Clinical evaluation of the use of indocyanine green for peeling the internal limiting membrane in macular hole surgery. Graefes Arch Clin Exp Ophthalmol 2006; 244: 291-297.
106. Foulquier S, Glacet-Bernard A, Sterkers M, Soubrane G, Coscas G. [Study of internal limiting membrane peeling in stage-3 and -4 idiopathic macular hole surgery]. J Fr Ophtalmol 2002; 25: 1026-1031.
107. Garweg JG, Bergstein D, Windisch B, Koerner F, Halberstadt M. Recovery of visual field and acuity after removal of epiretinal and inner limiting membranes. Br J Ophthalmol 2008; 92: 220-224.
108. Kiilgaard JF, Nissen MH, la Cour M. An isotonic preparation of 1 mg/ml indocyanine green is not toxic to hyperconfluent ARPE19 cells, even after prolonged exposure. Acta Ophthalmol Scand 2006; 84: 42-46.
109. Kodjikian L, Richter T, Halberstadt M, Beby F, Flueckiger F, Boehnke M et al. Toxic effects of indocyanine green, infracyanine green, and trypan blue on the human retinal pigmented epithelium. Graefes Arch Clin Exp Ophthalmol 2005; 243: 917-925.
110. Haritoglou C, Gandorfer A, Gass CA, Kampik A. Histology of the vitreoretinal interface after staining of the internal limiting membrane using glucose 5% diluted indocyanine and infracyanine green. Am J Ophthalmol 2004; 137: 345-348.
111. Dubreuil F, Ullern M, Lozato P, Rodrigues-Grillon S, Baudouin C. [Advantages of confocal microscopy in the analysis of epiretinal membranes and internal limiting membranes after macular surgery]. J Fr Ophtalmol 2005; 28: 19-29.